Provascular anticancer therapy

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Provascular anticancer therapy
Specialty oncology

Provascular anticancer therapy is a strategy that exploits the differential reactivity of mature tumor blood vessels to increase the efficacy of conventional anticancer treatments (such as radiotherapy and chemotherapy).[1] Based on the identification of an altered regulation of vascular reactivity in tumors, the provascular approach aims at selectively inducing a transient dilation of functional tumor microvessels, leading to increased tumor perfusion, increased drug delivery and increased tumor oxygenation and radiosensitivity.

References[edit]

  1. ^ Feron O (October 2004). "Targeting the tumor vascular compartment to improve conventional cancer therapy". Trends Pharmacol. Sci. 25 (10): 536–42. doi:10.1016/j.tips.2004.08.008. PMID 15380938.